Xanomeline and Trospium: A Potential Fixed Drug Combination (FDC) for Schizophrenia —A Brief Review of Current Data
by Alok Singh, MD Dr. Singh is with All India Institute of Medical Sciences in Raipur, India. Funding: No funding was provided for this study. Disclosures: The author has no conflicts of interest relevant to the contents of this article. Innov Clin Neurosci. 2022;19(10–12):43–47. Abstract Xanomeline, a cholinergic agonist, was initially evaluated for the treatment […]
The post Xanomeline and Trospium: A Potential Fixed Drug Combination (FDC) for Schizophrenia—A Brief Review of Current Data appeared first on Innovations in Clinical Neuroscience.
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: ICNS Online Editor Tags: Current Issue Drug Development Review Schizophrenia trospium xanomeline Source Type: research